Filing Details

Accession Number:
0001643346-17-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-03-17 16:43:54
Reporting Period:
2017-03-15
Filing Date:
2017-03-17
Accepted Time:
2017-03-17 16:43:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1628908 Evolent Health Inc. EVH Services-Management Services (8741) 320454912
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643346 Seth Blackley C/O Evolent Health, Inc.
800 North Glebe Road, Suite 500
Arlington VA 22203
President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Disposition 2017-03-15 10,396 $20.68 825,548 No 4 S Direct
Class A Common Stock Disposition 2017-03-15 4,604 $21.29 820,944 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 9, 2016.
  2. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $20.15-$21.10, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate prices within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $21.20-$21.40, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.